EPHA Access to Medicines Dialogues: The EU's IP strategy: Enabler or barrier?

 Registration is closed for this event
Patent-driven innovation may work for profit-driven drug development but it reflects an R&I agenda which favours profit prospects, distortion of competition and market dominance.
When
27 October 2020 17:00 through  6:00 PM
Contact